Trial Profile
A phase I multiple ascending dose trial of FAB 001 in healthy volunteers.
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2012
Price :
$35
*
At a glance
- Drugs FAB 001 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- 03 Oct 2012 New trial record